Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,015 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: A Systematic Review (French ccAFU).
Saouli A, Ruffion A, Dariane C, Barret E, Fiard G, Hankard GF, Créhange G, Roubaud G, Beauval JB, Brureau L, Renard-Penna R, Gauthé M, Baboudjian M, Ploussard G, Rouprêt M. Saouli A, et al. Among authors: roupret m. Cancers (Basel). 2023 Nov 20;15(22):5485. doi: 10.3390/cancers15225485. Cancers (Basel). 2023. PMID: 38001745 Free PMC article. Review.
Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial Group.
Marcq G, Afferi L, Neuzillet Y, Nykopp T, Voskuilen CS, Furrer MA, Kassouf W, Aziz A, Bajeot AS, Alvarez-Maestro M, Black P, Roupret M, Noon AP, Seiler R, Hendricksen K, Roumiguie M, Pang KH, Laine-Caroff P, Xylinas E, Ploussard G, Moschini M, Sargos P; YAU Urothelial Group. Marcq G, et al. Among authors: roupret m. Cancers (Basel). 2022 Nov 22;14(23):5740. doi: 10.3390/cancers14235740. Cancers (Basel). 2022. PMID: 36497222 Free PMC article.
Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis.
Grossmann NC, Soria F, Juvet T, Potretzke AM, Djaladat H, Ghoreifi A, Kikuchi E, Mari A, Khene ZE, Fujita K, Raman JD, Breda A, Fontana M, Sfakianos JP, Pfail JL, Laukhtina E, Rajwa P, Pallauf M, Poyet C, Cacciamani GE, van Doeveren T, Boormans JL, Antonelli A, Jamil M, Abdollah F, Ploussard G, Heidenreich A, Storz E, Daneshmand S, Boorjian SA, Rouprêt M, Rink M, Shariat SF, Pradere B. Grossmann NC, et al. Among authors: roupret m. Cancers (Basel). 2023 Feb 23;15(5):1409. doi: 10.3390/cancers15051409. Cancers (Basel). 2023. PMID: 36900201 Free PMC article.
Nephrectomy for kidney tumour increases the risk of de novo arterial hypertension.
Bigot P, Bernhard JC, Khene ZE, Dariane C, Lebdai S, Doumerc N, Nouhaud FX, Ouzaid I, Saulnier P, Méjean A, Roupret M, Bensalah K; French Committee of Urologic Oncology. Bigot P, et al. Among authors: roupret m. BJU Int. 2023 Nov;132(5):575-580. doi: 10.1111/bju.16124. Epub 2023 Jul 26. BJU Int. 2023. PMID: 37433580
Real-life Perioperative Outcomes of Radical Prostatectomy using the French National Registry: A Plea for Promotion of Centralized Care and Access to Minimally Invasive Approaches.
Baboudjian M, Grabia A, Barret E, Mathieu R, Rozet F, Lequeu CE, Rouprêt M, Ploussard G. Baboudjian M, et al. Among authors: roupret m. Eur Urol Oncol. 2023 Oct 18:S2588-9311(23)00222-5. doi: 10.1016/j.euo.2023.10.006. Online ahead of print. Eur Urol Oncol. 2023. PMID: 37863772
Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial.
Pfister C, Harter V, Allory Y, Radvanyi F, Culine S; VESPER Trial Investigators. Pfister C, et al. Contemp Clin Trials Commun. 2020 Jan 30;17:100536. doi: 10.1016/j.conctc.2020.100536. eCollection 2020 Mar. Contemp Clin Trials Commun. 2020. PMID: 32083220 Free PMC article.
Machine-learning approach for prediction of pT3a upstaging and outcomes of localized renal cell carcinoma (UroCCR-15).
Boulenger de Hauteclocque A, Ferrer L, Ambrosetti D, Ricard S, Bigot P, Bensalah K, Henon F, Doumerc N, Méjean A, Verkarre V, Dariane C, Larré S, Champy C, de La Taille A, Bruyère F, Rouprêt M, Paparel P, Droupy S, Fontenil A, Patard JJ, Durand X, Waeckel T, Lang H, Lebâcle C, Guy L, Pignot G, Durand M, Long JA, Charles T, Xylinas E, Boissier R, Yacoub M, Colin T, Bernhard JC. Boulenger de Hauteclocque A, et al. Among authors: roupret m. BJU Int. 2023 Aug;132(2):160-169. doi: 10.1111/bju.15959. Epub 2023 Feb 1. BJU Int. 2023. PMID: 36648124
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study.
Pfister C, Gravis G, Flechon A, Chevreau C, Mahammedi H, Laguerre B, Guillot A, Joly F, Soulie M, Allory Y, Harter V, Culine S; VESPER Trial Investigators. Pfister C, et al. Lancet Oncol. 2024 Feb;25(2):255-264. doi: 10.1016/S1470-2045(23)00587-9. Epub 2023 Dec 21. Lancet Oncol. 2024. PMID: 38142702 Clinical Trial.
A Systematic Review and Meta-analysis of the Impact of Local Therapies on Local Event Suppression in Metastatic Hormone-sensitive Prostate Cancer.
Tsuboi I, Matsukawa A, Kardoust Parizi M, Klemm J, Mancon S, Chiujdea S, Fazekas T, Miszczyk M, Laukhtina E, Kawada T, Katayama S, Iwata T, Bekku K, Karakiewicz P, Wada K, Rouprêt M, Araki M, Shariat SF. Tsuboi I, et al. Among authors: roupret m. Eur Urol Oncol. 2024 Apr 3:S2588-9311(24)00083-X. doi: 10.1016/j.euo.2024.03.007. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38575408 Free article. Review.
1,015 results